The page is the record's research on the issuer — no analyst, no rating, no view.

Karyopharm Therapeutics Inc. (KPTI) — research page

US · us-cm-kg/NASDAQ/KPTI · as of 2026-11-08

Identity and listing

The issuer is Karyopharm Therapeutics Inc., listed on NASDAQ under ticker KPTI, with ISIN US48576U2050 and LEI 549300J1VANRCNTYST87. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Segment is not on the record. Its listing status is listed, not halted.

fieldvaluesource · read date
nameKaryopharm Therapeutics Inc.source · 2026-11-08
exchangeNASDAQsource · 2026-11-08
tickerKPTIsource · 2026-11-08
ISINUS48576U2050source · 2026-10-05
LEI549300J1VANRCNTYST87source · 2026-11-08
security typeCorporatesource · 2026-11-08
segmentnot on the record
sector2834 Pharmaceutical Preparationssource · 2026-11-08
jurisdictionUnited States — Delawaresource · 2026-11-08
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 96 filings in the twelve months to 2026-11-08, across 55 filing days. The median gap between filing days is 5.0 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. The latest filing is dated 2026-11-05 and is of type halt_suspension, 3 days before the record date. Median filings for NASDAQ are 52 and for the sector 63.0; median latency is 5.0 days for NASDAQ and 4.0 days for the sector.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer9653
exchange median: NASDAQ (4359 issuers)5265
sector median: 2834 Pharmaceutical Preparations (526 issuers)6364
datetypecategoryfiling
2026-11-05halt_suspension8-K8-K — 8-K (items 3.01)
2026-11-03corporate_news8-K8-K — 8-K (items 1.01,1.03,2.03,2.04,7.01,8.01,9.01)
2026-11-02corporate_news8-K8-K — 8-K (items 7.01,9.01)
2026-10-28regulatory_filingSCHEDULE 13G/ASCHEDULE 13G/A
2026-10-22corporate_news8-K8-K — 8-K (items 8.01)

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change lines. Domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names 3 research houses: Cantor, H.C. Wainwright & Co., and Jefferies, LLC.

research houseanalystsource · read date
CantorYanni Souroutzidisissuer page · 2026-11-11
H.C. Wainwright & Co.Robert Burnsissuer page · 2026-11-11
Jefferies, LLCMaury Raycroftissuer page · 2026-11-11

Open research

No openly published research notes were found for the issuer.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The record seals the issuer's years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
10.2
https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
10.3
https://data.sec.gov/submissions/CIK0001503802.json (identity.jurisdiction)
10.4
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5
https://mcp.us-cm-kg.ai/events/NASDAQ/KPTI (the disclosure lines)
10.6
https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
10.7
https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
10.8
https://investors.karyopharm.com/analyst-coverage (coverage)
10.9
https://mcp.us-cm-kg.ai/record/NASDAQ/KPTI (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US48576U2050"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:c689582940e822bb.